1[1]Milner JA, Stepanovich LV. Inhibitory effect of dietary arginine on growth of Ehrlich ascites tumor cells in mice. J Nutr ,1979 , 109(3):489~494. 被引量:1
2[2]Sheng-long Ye, MD, MS, et al. Tumor and host response to arginine and branched chain amino acid-enriched total parenteral nutrition. Cancer ,1992,69:261~270. 被引量:1
3[3]Edwards PD, Topping D, Kontaridis MI,et al. Arginine-enhanced enteral nutrition augments the growth of a nitric oxide-producing tumor. JPEN J Parenter Enteral Nutr, 1997,21(4):215~219. 被引量:1
4[4]Park KGM, Heys SD, Blessing K, et al. Stimulation of human breast cancers by dietartary L-arginine.Clin Sci,1992, 82: 413. 被引量:1
5[5]Terrault NA, Zhou S, McCory RW, et al. Incidence and clinical consequences of surface and polymerase gene mutations in liver transplant recipients on hepatitis B immunoglobulin. Hepatology, 1998, 28(2): 555. 被引量:1
6[6]Grossie VB Jr,Nishioka K. Effect of ornithine in parenteral nutrition regimens on difluoromethy-lornithine-induced platelet suppression and changes in tumor polyamine content. Cancer Invest,1998,16(3): 160. 被引量:1
7[7]Grossie VB Jr, Nishioka K, Ajani JA, et al. Substituting ornithine for arginine in total parenteral nutrition eliminates enhanced tumor growth. J Surg Oncol 1992,50(3):161. 被引量:1